Beyond trastuzumab: new treatment options for HER2-positive breast cancer.

Authors : Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart-Gebhart M
Year : 2011
Journal : Breast
Volume : 20 Suppl 3
Pages : S20-7

HER2-overexpressing breast cancer: time for the cure with less chemotherapy?

Authors : Loi S, de Azambuja E, Pugliano L, Sotiriou C, Piccart-Gebhart M
Year : 2011
Journal : Curr Opin Oncol
Volume : 23(6)
Pages : 547-58

Improving quality of life after breast cancer: dealing with symptoms.

Authors : Pinto AC, de Azambuja E
Year : 2011
Journal : Maturitas
Volume : 70(4)
Pages : 343-8

The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties.

Authors : Raicevic G, Najar M, Stamatopoulos B, De Bruyn C, Meuleman N, Bron D, Toungouz M, Lagneaux L
Year : 2011
Journal : Cell. Immunol.
Volume : 270(2)
Pages : 207-16

Non Hodgkin's lymphomas: a major breakthrough with immunotherapy].

Authors : Firescu R, Muylle K, Roelandts M, de Wind A, Moerman C, Lemort M, Kentos A, Meuleman N, Bron D
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 83-92

Invasive mechanical ventilation in cancer patients. Prior non invasive ventilation is a poor prognostic factor.

Authors : Meert AP, Berghmans T, Markiewicz E, Hardy M, Nayer N, Paesmans M, Sculier JP
Year : 2011
Journal : J BUON
Volume : 16(1)
Pages : 160-5

C-erbB-3 expression in non-small cell lung cancer (NSCLC) patients treated by Erlotinib.

Authors : CsToth I, Anthoine G, Berghmans T, Mascaux C, Paesmans M, Sculier JP, Meert AP
Year : 2011
Journal : Anticancer Res
Volume : 31(1)
Pages : 281-5

Febrile neutropenia at the emergency department of a cancer hospital].

Authors : Debey C, Meert AP, Berghmans T, Thomas JM, Sculier JP
Year : 2011
Journal : Rev Med Brux
Volume : 32(2)
Pages : 74-82

Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables.

Authors : Berghmans T, Paesmans M, Sculier JP
Year : 2011
Journal : Ther Adv Med Oncol
Volume : 3(3)
Pages : 127-38

Positron emission tomography with 18F-FDG and cancer response to chemotherapy].

Authors : van Ruychevelt V, Garcia C, Meert AP, Berghmans T, Paesmans M, Flamen P, Sculier JP
Year : 2011
Journal : Rev Mal Respir
Volume : 28(5)
Pages : 618-25

Salvage with erlotinib plus bevacizumab: not in NSCLC.

Authors : Sculier JP, Meert AP, Berghmans T
Year : 2011
Journal : Lancet
Volume : 377(9780)
Pages : 1810-2

A rare cause of superior vena cava syndrome].

Authors : Lepida A, Berghmans T, Sculier JP, Meert AP
Year : 2011
Journal : Rev Med Brux
Volume : 32(5)
Pages : 481-3

Validation and comparison of several published prognostic systems for patients with small cell lung cancer.

Authors : Paesmans M, Lafitte JJ, Lecomte J, Berghmans T, Efremidis A, Giner V, Van Cutsem O, Scherpereel A, Meert AP, Leclercq N, Van Houtte P, Sculier JP
Year : 2011
Journal : Eur. Respir. J.
Volume : 38(3)
Pages : 657-63

Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.

Authors : Gianni L, Dafni U, Gelber Rd, de Azambuja E, Muehlbauer S, Goldhirsch A, Untch M, Smith I, Baselga J, Jackisch C, Cameron D, Mano M, Pedrini JL, Veronesi A, Mendiola C, Pluzanska A, Semiglazov V, Vrdoljak E, Eckart MJ, Shen Z, Skiadopoulos G, Procter M, Pritchard KI, Piccart-Gebhart M, Bell R
Year : 2011
Journal : Lancet Oncol
Volume : 12(3)
Pages : 236-44

A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study.

Authors : Villanueva C, Awada A, Campone M, Machiels JP, Besse T, Magherini E, Dubin F, Semiond D, Pivot X
Year : 2011
Journal : Eur. J. Cancer
Volume : 47(7)
Pages : 1037-45

High-throughput sequencing reveals novel microRNAs in a retrovirus-induced ovine model of leukemia. (TEXTBOOK Keystone meeting MicroRNAs and non-coding RNAs in cancer, Banff, Canada, February 10-16, 2011)

Authors : Rosewick N, Dehouck C, Cleuter Y, Caiment F, Georges M, Martiat P, Burny A, Van den Broeke A
Year : 2011
Journal : Book
Volume : -
Pages : -

Méthodologie et analyse des essais cliniques, in “Cours de chimiothérapie antitumorale et traitement médical du cancer: 26e cours de l'Institut de cancérologie Gustave-Roussy.” (TEXTBOOK Edited by JC. Soria, S. Vignot, C. Massard, O. Mir. John Libby

Authors : Michiels S
Year : 2011
Journal : Book
Volume : -
Pages : -

Facteurs pronostiques et prédictifs de la réponse un traitement. Invited chapter in “Méthodes biostatistiques appliquées la recherche clinique en cancérologie”. (TEXTBOOK Edited by A. Kramar A. and S. Mathoulin-Pelissier. John Libbey Eurotext)

Authors : Paoletti X, Mathoulin-Pelissier S, Michiels S
Year : 2011
Journal : Book
Volume : -
Pages : -

Introduction to Gene Expression Profiling In Breast Cancer in “Breast Surgical techniques and Interdisciplinary Management”, (TEXTBOOK Dirbas FM. & Scott-Conner C.E.H. Editors (Springer, 2011 - 440 pages).

Authors : Dirbas FM, Sotiriou C
Year : 2011
Journal : Book
Volume : -
Pages : -

Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.

Authors : Michiels S, Potthoff RF, George SL
Year : 2011
Journal : Stat Med
Volume : 30(13)
Pages : 1502-18